AMSTERDAM, Nov. 14, 2017 /PRNewswire/ -- Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the results of a comprehensive, independent, two-year
study demonstrating the clinical workflow benefits of its next
generation image-guided therapy platform, Azurion. The study
investigated nearly 800 patient procedures to evaluate the impact
of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated
clinicians' use of Azurion resulted in significant time
savings for the hospital, including a 17 percent reduction of the
average interventional procedure time, a 12 percent reduction of
in-lab patient preparation time, and a 28 percent reduction of
post-procedure lab time.
"As the use of image-guided therapies continue to rise, new
systems need to be easy and intuitive to use so clinicians can
quickly and efficiently move through procedures," said Marco van
Strijen, MD, Interventional Radiologist, St. Antonius Hospital.
"With the Azurion system, we were able to change our workflow in
such a way that we now can do more patients in a single day,
resulting in more patients a week, resulting in more patients per
year, with no compromise to patient safety or quality of care."
Overall, the improvements achieved with Azurion will give St.
Antonius Hospital the ability to treat one more patient per day –
on an average of 6 to 8 patients per day, to help hundreds more
patients each year. The reduced preparation, procedure and lab time
resulted in fewer planned cases finishing after normal working
hours and higher employee satisfaction. St. Antonius Hospital,
treating more than 93,000 patients annually, was among the first
hospitals to install Azurion and participated in this comprehensive
study to evaluate the impact of the new platform and its clinical
workflow on their department.
"Hospitals are facing a hard to predict and growing patient
demand and needed a solution that provides impactful clinical and
operational improvements," said Ronald Tabaksblat, Business Leader
Image Guided Therapy Systems. "Less than a year after Azurion's
official launch, we're delighted with these impressive results that
clearly demonstrate how Azurion's state-of-the-art technology and
flexible workflows are helping hospitals increase efficiency and
optimize patient care."
Future of image-guided therapy
Azurion is Philips'
next generation image-guided therapy platform and the new core of
its integrated image-guided therapy solutions portfolio. Azurion
supports a full range of configurations across a broad spectrum of
image-guided therapy procedures. It helps physicians perform
interventional procedures through an intuitive interface and
easy-to-use controls for clinical image capture, decreasing
procedure times and allowing for more accurate scheduling of
patients. Additionally, Azurion makes it easier for staff to
anticipate and see the information they need, when they need it,
helping procedures flow more efficiently and easily.
Since its global introduction in February
2017, over 20,000 patients have been treated in 24 countries
across the world. St. Antonius Hospital is the first of a series of
hospital studies. In 2018 more hospitals worldwide will share
results demonstrating Azurion's impact and benefits in improving
clinical workflow and ultimately optimizing patient care.
"The success achieved was possible due to the deep and trusted
partnership we have with Philips," said Wout Adema, member of the Santeon Procurement
Board and Chief Financial Officer, St. Antonius Hospital. "The
Azurion installation provided our interventional team the
opportunity to evaluate our existing processes and standardize
workflows. This helped us make tangible and significant operational
improvements in the short-term, and fostered a continuous
improvement culture amongst the team. The positive impact on
patient and staff satisfaction further contributes to our
reputation as a leading vascular institute."
Visit Philips at the RSNA 2017 Annual meeting
During
the Radiological Society of North
America's (RSNA) 2017 Annual Meeting, November 26 to December 2, 2017 in Chicago, attendees will have the opportunity
to experience Azurion first-hand at the Philips booth #6735. Find
out more online here or visit www.philips.com/labperformance to
learn more about the study.
For further information, please contact:
Steve Klink
Philips Group Press Office
Tel: +31 6 10888824
Email: steve.klink@philips.com
Fabienne van der Feer
Philips Image Guided Therapy
Tel: +31 6-22698001
E-mail: fabienne.van.der.feer@philips.com
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, image-guided therapy, patient monitoring and
health informatics, as well as in consumer health and home care.
Philips' health technology portfolio generated 2016 sales of
EUR 17.4 billion and employs
approximately 73,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter
View original content with
multimedia:http://www.prnewswire.com/news-releases/new-study-demonstrates-significant-clinical-workflow-and-staff-experience-benefits-of-philips-azurion-image-guided-therapy-platform-300555289.html
SOURCE Royal Philips